ACTIVE

PHARMA 4

Export PDF

Financial year 2024 · closed on 31/12/2024

Net result

92,2 k €

+1.2% YoY

Gross margin

335,9 k €

-11.2% YoY

Equity

513,9 k €

+11.3% YoY

Workforce

3,5 ETP

-14.6% YoY

What does PHARMA 4 do?

PHARMA 4 is a Private limited company incorporated in 2006. Its registered office is in Bruxelles. It employs on average 3,5 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0885.226.948

Incorporation

24/11/2006

Legal form

Private limited company

Registered office

Rue de Flandre 4
1000 Bruxelles · BruxellesSee on map

Contributed capital

18 600,00 €

Latest accounts

31/12/2024

Average workforce

3,5 ETP

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 18 financial years

	2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007
Income statement
Gross margin	335,9 k €	-11.2%	378,1 k €	+2.9%	367,5 k €	+6.6%	344,7 k €	+9.3%	315,2 k €	+14.3%	275,8 k €	-4.4%	288,6 k €	+35.9%	212,4 k €	-33.5%	319,2 k €	+16.0%	275,2 k €	+1.1%	272,2 k €	-22.9%	353,1 k €	+22.9%	287,4 k €	+4.3%	275,5 k €	-15.4%	325,6 k €	+13.2%	287,5 k €	+1.2%	284,1 k €	+18.9%	239 k €
EBITDA	118 k €	-25.5%	158,5 k €	+7.0%	148,2 k €	-30.7%	213,7 k €	+39.8%	152,8 k €	+157%	59,4 k €	-33.4%	89,2 k €	+59.8%	55,8 k €	-66.7%	167,5 k €	+13.0%	148,2 k €	+10.1%	134,7 k €	-10.7%	150,7 k €	+84.1%	81,9 k €	+8.0%	75,8 k €	-36.9%	120,1 k €	+23.9%	97 k €	-0.4%	97,3 k €	+44.0%	67,6 k €
Operating result	112,6 k €	-12.0%	128 k €	+10.7%	115,6 k €	-29.4%	163,8 k €	+63.5%	100,2 k €	+1046%	8,7 k €	-77.2%	38,4 k €	+979%	3,6 k €	-93.7%	56,4 k €	+54.3%	36,5 k €	+87.9%	19,4 k €	-54.5%	42,7 k €	+267%	-25,6 k €	-301%	-6,4 k €	-112%	55,4 k €	+80.1%	30,8 k €	-1.6%	31,3 k €	+611%	4,4 k €
Net result	92,2 k €	+1.2%	91,1 k €	+8.3%	84,1 k €	-27.3%	115,6 k €	+60.6%	72 k €	+2872%	-2,6 k €	-112%	21,3 k €	+389%	-7,4 k €	-124%	30,2 k €	+71.2%	17,6 k €	+217%	5,6 k €	-80.6%	28,6 k €	+171%	-40,1 k €	-230%	-12,1 k €	-139%	31,3 k €	+130%	13,6 k €	-23.4%	17,8 k €	+1167%	1,4 k €
Balance sheet
Equity	513,9 k €	+11.3%	461,7 k €	+24.6%	370,6 k €	+29.4%	286,5 k €	+46.3%	195,9 k €	+58.1%	123,9 k €	-2.1%	126,5 k €	+20.3%	105,2 k €	+5.0%	100,2 k €	+43.2%	70 k €	+33.7%	52,3 k €	+11.9%	46,7 k €	+158%	18,1 k €	-68.9%	58,2 k €	-17.3%	70,3 k €	+80.3%	39 k €	+53.6%	25,4 k €	+234%	7,6 k €
Total assets	879,5 k €	+49.0%	590,2 k €	+18.0%	500 k €	-2.3%	511,7 k €	+0.3%	509,9 k €	-8.1%	555,1 k €	-2.0%	566,2 k €	-8.3%	617,4 k €	-6.2%	658,4 k €	-7.6%	712,2 k €	-8.7%	779,9 k €	-8.4%	851,5 k €	-7.7%	923 k €	+21.3%	760,9 k €	-1.2%	770 k €	+3.9%	740,9 k €	-1.9%	755,5 k €	-20.6%	951,8 k €
Cash	246,6 k €	-1.5%	250,4 k €	+127%	110,4 k €	-16.9%	132,7 k €	+2.5%	129,5 k €	+53.7%	84,2 k €	-12.0%	95,7 k €	+22.6%	78,1 k €	-9.6%	86,4 k €	+19.1%	72,6 k €	-3.6%	75,3 k €	-12.6%	86,2 k €	+30.5%	66 k €	-41.5%	113 k €	-15.9%	134,3 k €	+50.5%	89,3 k €	+25.4%	71,2 k €	-66.4%	211,9 k €
Debts	365,6 k €	+185%	128,4 k €	-0.7%	129,3 k €	-42.6%	225,1 k €	-28.3%	314,1 k €	-27.2%	431,2 k €	-1.9%	439,7 k €	-14.2%	512,2 k €	-8.2%	558,2 k €	-13.1%	642,3 k €	-11.7%	727,6 k €	-9.6%	804,8 k €	-11.1%	904,9 k €	+28.8%	702,7 k €	+0.4%	699,7 k €	-0.3%	701,9 k €	-3.9%	730,1 k €	-22.7%	944,2 k €
Other
Workforce	3,5 ETP	-14.6%	4,1 ETP	-4.7%	4,3 ETP	-2.3%	4,4 ETP	0.0%	4,4 ETP	+2.3%	4,3 ETP	+4.9%	4,1 ETP	+7.9%	3,8 ETP	+26.7%	3,0 ETP	0.0%	3,0 ETP	-16.7%	3,6 ETP	+2.9%	3,5 ETP	0.0%	3,5 ETP	-7.9%	3,8 ETP	-2.6%	3,9 ETP	+5.4%	3,7 ETP	0.0%	3,7 ETP	0.0%	3,7 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 6 ended

Active mandates

AWM PHARMA

Director · since 01 juillet 2024 · 1005.406.780

Represented by Asmaa WAHIB MOUSSA

Active

Ended mandates

Annie Coens

Mandate

Ended

ANNIE COENS

Director

Ended

ANNIE COENS

Administrator - manager

Ended

ERIC VAN OBBERGEN

Director

Ended

At this address

Other companies at this address

Company	CBE no.
AWM PHARMA● Active	1005.406.780
MODERN BLOCKS Consulting● Active	0666.541.141

Annual accounts

Full financial information

	2024	2023	2022	2021	2020	2019
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	02/07/2025	28/06/2024	05/06/2023	14/07/2022	25/06/2021	02/06/2020
General meeting	30/05/2025	28/03/2024	26/05/2023	27/05/2022	28/05/2021	29/05/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

18 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2024	30/05/2025	02/07/2025	French	PDF
Abridged model	31/12/2023	28/03/2024	28/06/2024	French	PDF
Abridged model	31/12/2022	26/05/2023	05/06/2023	French	PDF
Abridged model	31/12/2021	27/05/2022	14/07/2022	French	PDF
Abridged model	31/12/2020	28/05/2021	25/06/2021	French	PDF
Abridged model	31/12/2019	29/05/2020	02/06/2020	French	PDF
Abridged model	31/12/2018	31/05/2019	19/06/2019	French	PDF
Abridged model	31/12/2017	25/05/2018	22/06/2018	French	PDF
Abridged model	31/12/2016	26/05/2017	23/06/2017	French	PDF
Abridged model	31/12/2015	27/05/2016	21/06/2016	French	PDF
Abridged model	31/12/2014	29/05/2015	29/05/2015	French	PDF
Abridged model	31/12/2013	30/05/2014	25/06/2014	French	PDF
Abridged model	31/12/2012	31/05/2013	04/06/2013	French	PDF
Abridged model	31/12/2011	25/05/2012	19/06/2012	French	PDF
Abridged model	31/12/2010	27/05/2011	23/06/2011	French	PDF
Abridged model	31/12/2009	28/05/2010	18/06/2010	French	PDF
Abridged model	31/12/2008	29/05/2009	22/06/2009	French	PDF
Abridged model	31/12/2007	30/05/2008	17/06/2008	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 6 ended

Active mandates

AWM PHARMA

Director · since 01 juillet 2024 · 1005.406.780

Represented by Asmaa WAHIB MOUSSA

Active

Ended mandates

Annie Coens

Mandate

Ended

ANNIE COENS

Director

Ended

ANNIE COENS

Administrator - manager

Ended

ERIC VAN OBBERGEN

Director

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates19/07/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates19/10/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
PDF
Other04/07/2007
DIVERS
PDF
Other04/12/2006
RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2024
Annual accounts 202492,2 k €↑
2023
Annual accounts 202391,1 k €↑
2022
Annual accounts 202284,1 k €↓
2021
Annual accounts 2021115,6 k €↑
2020
Annual accounts 202072 k €↑
2019
Annual accounts 2019-2,6 k €↓
2018
Annual accounts 201821,3 k €↑
2017
Annual accounts 2017-7,4 k €↓
2016
Annual accounts 201630,2 k €↑
2015
Annual accounts 201517,6 k €↑
2014
Annual accounts 20145,6 k €↓
2013
Annual accounts 201328,6 k €↑
2012
Annual accounts 2012-40,1 k €↓
2011
Annual accounts 2011-12,1 k €↓
2010
Annual accounts 201031,3 k €↑
2009
Annual accounts 200913,6 k €↓
2008
Annual accounts 200817,8 k €↑
2007
Annual accounts 20071,4 k €
24/11/2006
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMA 4

Overview

What does PHARMA 4 do?

Trend over 18 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline